Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind active-controlled study of freeze-dried human rabies vaccine (2BS cells) using different immunization schedules in healthy participants
CTR20221775Phase 3Active
- Sponsor
- Chengdu Institute of Biological Products
- Start
- Oct 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated rabies vaccine in rabies, sponsored by Chengdu Institute of Biological Products. Started Oct 2022; status: active.
02
Drugs
inactivated rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20221775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221775.